We serve Chemical Name:(S)-Glycidyl tosylate CAS:70987-78-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(S)-Glycidyl tosylate
CAS.NO:70987-78-9
Synonyms:(2S)-2-Oxiranylmethyl 4-methylbenzenesulfonate;T3OTJ B1OSWR D1 &&S Form;EINECS 417-210-7;[(2S)-oxiran-2-yl]methyl 4-methylbenzenesulfonate;(2S)-Glycidyl tosylate;2-Oxiranemethanol, 4-methylbenzenesulfonate, (2S)-;MFCD00064489;(2S)-Oxiran-2-ylmethyl-4-methylbenzolsulfonat;(2S)-Oxiran-2-ylmethyl 4-methylbenzenesulfonate;(S)-Glycidyl tosylate;(S)-(+)-Glycidyl tosylate
Molecular Formula:C10H12O4S
Molecular Weight:228.265
HS Code:29109000
Physical and Chemical Properties:
Melting point:45-48ºC
Boiling point:370.5±15.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.550
PSA:64.28000
Exact Mass:228.045624
LogP:1.35
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3077
Packing Group:
Contact us for information like (2S)-2-Oxiranylmethyl 4-methylbenzenesulfonate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-(+)-Glycidyl tosylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2S)-2-Oxiranylmethyl 4-methylbenzenesulfonate Use and application,(S)-Glycidyl tosylate technical grade,usp/ep/jp grade.
Related News: CanSinoBIO’s inhaled COVID-19 vaccine candidate was found to trigger immune responses with no serious side effects reported, according to an early-stage clinical study. 2-(3,4-Dichlorophenyl)ethanol manufacturers Officials did, however, acknowledge that there’s growing evidence an extra jab may enhance the antibody response in immunocompromised people. Some small studies suggest up to 50% of people with no antibody response after the authorized regimen of two mRNA jabs developed a response after an additional dose, said CDC’s Sara Oliver, M.D. benzyl methyl disulfide suppliers J.P. Morgan and William Blair analysts still backed iRhythm for the long-term despite its recent challenges. William Blair analysts wrote that the company is still a leader of a cardiac monitoring market that is under 20% penetrated and valued at approximately $2 billion. Tebufenozide vendor & factory.
